OR

Browse By

Targeting CEP55 in triple-negative breast cancer (2022–2025)

Grant type:
United States Congressionally Directed Medical Research Programs - Breast Cancer Research Program
Researchers:

  • Professor David Fairlie

    NHMRC Leadership Fellow and Group L
    Institute for Molecular Bioscience
    NHMRC Leadership Fellow and Group L
    Institute for Molecular Bioscience
    Affiliate of ARC COE for Innovation
    ARC Centre of Excellence for Innovations in Peptide and Protein Science
    Institute for Molecular Bioscience
    of Institute for Molecular Bioscien
    Institute for Molecular Bioscience
Funded by:
United States Department of Defense